{
    "clinical_study": {
        "@rank": "80515", 
        "arm_group": [
            {
                "arm_group_label": "Traumatic Brain Injury", 
                "description": "Patients who present to the health care facility with mild or moderate traumatic brain injury (Glasgow Coma Scale 9-15) within 4 hours of injury"
            }, 
            {
                "arm_group_label": "Orthopedic Control", 
                "description": "Patients who present to the health care facility with isolated extracranial orthopedic injury within 4 hours of injury"
            }
        ], 
        "biospec_descr": {
            "textblock": "Whole blood, serum, plasma"
        }, 
        "biospec_retention": "Samples Without DNA", 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if specific brain injury biomarkers have utility\n      as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be\n      accomplished by examining the relationships between potential serum-based TBI biomarkers and\n      clinical measures of injury severity, occurrence of complications, and outcome, in subjects\n      with mild or moderate TBI as well as in orthopedic control subjects."
        }, 
        "brief_title": "Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI", 
        "completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "condition": "Brain Injuries, Traumatic", 
        "condition_browse": {
            "mesh_term": [
                "Brain Injuries", 
                "Wounds and Injuries"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Mild/Moderate TBI Group\n\n        Inclusion Criteria:\n\n          1. 18 years or older\n\n          2. GCS 9-15\n\n          3. CT scan as part of clinical evaluation\n\n          4. experienced some level of altered mental state at time of injury\n\n          5. determination of study eligibility within 4 hours of injury\n\n        Exclusion Criteria:\n\n          1. Pregnant females\n\n          2. Prisoners\n\n          3. Anemia or significant blood loss (hemoglobin < 12 mg/dL and/or hematocrit < 35%,\n             and/or clinical state requiring resuscitation with more than 6L of colloid or\n             crystalloid fluid)\n\n          4. no clear history of trauma as primary event\n\n          5. previous history of stroke, or head injury requiring hospitalization\n\n          6. dementia or psychotic illness or neurological condition which may affect outcome\n\n          7. unable to speak or understand English\n\n        Orthopedic Control Group\n\n        Inclusion Criteria:\n\n          1. 18 years or older\n\n          2. Isolated extracranial orthopedic injury, including fractures\n\n          3. Stable vital signs on presentation to ED (pulse < 100bpm and systolic blood pressure\n             > 100 mmHg)\n\n        Exclusion Criteria:\n\n          1. evidence of brain injury, including abnormal neurological examination, alteration in\n             consciousness, memory or mental status, headache, dizziness, or vomiting following\n             injury\n\n          2. not enrolled within 4 hours of injury\n\n          3. Pregnant females\n\n          4. Prisoners\n\n          5. Anemia or significant blood loss (hemoglobin < 12 mg/dL and/or hematocrit < 35%,\n             and/or clinical state requiring resuscitation with more than 6L of colloid or\n             crystalloid fluid)\n\n          6. previous history of stroke, or head injury requiring hospitalization"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Subjects who present to the health care facility with either Traumatic Brain Injury (GCS\n        9-15) or isolated extracranial orthopedic injury within 4 hours of injury"
            }
        }, 
        "enrollment": {
            "#text": "111", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01786447", 
            "org_study_id": "ATO-04a"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 8, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Detroit", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48201"
                }, 
                "name": "Wayne State University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "2", 
        "other_outcome": [
            {
                "measure": "Assessment of biomarkers to identify patients with acute post-injury alterations in mental status", 
                "safety_issue": "No", 
                "time_frame": "96 hours"
            }, 
            {
                "measure": "Assessment of biomarkers to identify patients that may have longer-term post-injury neurological deficits using neuropsychological assessments", 
                "safety_issue": "No", 
                "time_frame": "Day 30"
            }
        ], 
        "overall_official": {
            "affiliation": "Banyan Biomarkers", 
            "last_name": "Jackson Streeter, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Terminated", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Assessment of biomarkers to identify patients with TBI from orthopedic controls", 
            "safety_issue": "No", 
            "time_frame": "4 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01786447"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Assessment of biomarkers to identify patients with brain lesions on CT scan", 
            "safety_issue": "No", 
            "time_frame": "4 hours"
        }, 
        "source": "Banyan Biomarkers, Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Banyan Biomarkers, Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2010", 
        "study_design": "Observational Model: Case Control, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "February 2013"
    }
}